London Health Sciences Centre
Quick facts
Marketed products
- Mycophenolate to sirolimus switch · Immunology / Transplantation
A therapeutic strategy that replaces mycophenolate mofetil with sirolimus to reduce immunosuppressive burden while maintaining graft protection in transplant recipients.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: